Undoctored vault view

The Co-Chairs of Pou Tangata of the National Iwi Chair’s Forum (NICF), Mr Rahui Papa and Dame Naida Glavish, have today slammed Pharmac’s decision to cease funding the preventative treatment for respiratory syncytical virus (RSV) in young tamariki

New resources have been developed to guide medication reviews for older people on multiple medications to ensure patients are taking the right medication at the right time and in the right way

The planned end of the temporary funding for this treatment was due to the completion of the COVID-19 funding allocated by the government in response to the pandemic

Early feedback on the new cervical screening test introduced by Te Whatu Ora and Te Aka Whai Ora in September 2023 indicate it’s a game changer. Feedback from screen-takers across the country is that they are seeing more unscreened people coming forward for an HPV self-test.

As part of delivering on the Workforce Plan 2023/24, Te Whatu Ora has expanded next year’s Voluntary Bonding Scheme and added two new categories to the Scheme to encourage and retain recently qualified health professionals where we most need them.

Te Pātaka Whaioranga – Pharmac is calling for applications for medicines to treat rare disorders. These will be considered at the next meeting of the Rare Disorders Advisory Committee meeting in May 2024.

A recent spike in COVID-19 cases is a reminder for people who are at high-risk to make sure they’re up to date with their COVID-19 booster and to use antiviral medications early if they are infected with the virus.

A consultation document explaining the Pharmacy Council’s proposed Disciplinary levy and APC fee increases has been released today with submissions due no later than 9.00am Monday, 11 December 2023

The Pharmaceutical Society of New Zealand (PSNZ) is forming a national Education Advisory Group (EAG) to ensure educators and participants involved in PSNZ’s pharmacy education and training have an opportunity to discuss and provide feedback on educational issues, PSNZ President Rhiannon Braund announced today

Te Pātaka Whaioranga – Pharmac is consulting on a proposal to fund testosterone gel without restrictions as an additional testosterone treatment for those who need it.